“Focusing on IL-6 STAT3 Pathway Shows the Approach of Anti-IL-6 Antibody (tocilizumab) in the Treatment of Multiple Hydrocephalus”. Current Opinion 1, no. 01 (December 10, 2021): 15–19. Accessed January 23, 2025. https://currentopinion.info/index.php/co/article/view/14.